Akso Health Group (AHG) shareholders
Close on Nov 17, 2026Market cap $1.06BP/E 41.3Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AHG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 70,943 | 0.00% | $105.71K | −27,455 | 0.00% |
| Northern Trust Corp | 51,403 | 0.00% | $76.59K | +4,528 | 0.00% |
| Citadel Advisors LLC | 46,026 | 0.00% | $68.58K | New | 0.00% |
| SmartHarvest Portfolios, LLC | 44,755 | 0.00% | $66.69K | +9,326 | 0.02% |
| Jane Street Group, LLC | 41,360 | 0.00% | $61.63K | +10,123 | 0.00% |
| Geode Capital Management, LLC | 14,973 | 0.00% | $22.31K | – | 0.00% |
| BlackRock, Inc. | 10,064 | 0.00% | $15.00K | +10,027 | 0.00% |
| UBS Group AG | 963 | 0.00% | $1.43K | New | 0.00% |
| Morgan Stanley | 739 | 0.00% | $1.10K | New | 0.00% |
| Huntington National Bank | 419 | 0.00% | $624 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 2 | 0.00% | $3 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 11 | 0M | 0.0% | 5 / 4 | 1 / 0 | 0M | 0M |
| Q1 2026 | 6 | 0M | 0.0% | 1 / 2 | 1 / 0 | 0M | 0M |
| Q4 2025 | 5 | 0M | 0.0% | 2 / 0 | 1 / 1 | 0M | 0M |
| Q3 2025 | 4 | 0M | 0.0% | 1 / 1 | 1 / 2 | 0M | 0M |
| Q2 2025 | 5 | 0M | 0.0% | 0 / 1 | 3 / 3 | 0M | 0M |
| Q1 2025 | 8 | 0M | 0.0% | 1 / 3 | 3 / 1 | 0M | 0M |
| Q4 2024 | 8 | 0M | 0.0% | 2 / 2 | 2 / 0 | 0M | 0M |
| Q3 2024 | 6 | 0M | 0.0% | 1 / 0 | 3 / 1 | 0M | 0M |
| Q2 2024 | 6 | 0M | 0.0% | 1 / 1 | 2 / 1 | 0M | 0M |
| Q1 2024 | 6 | 0M | 0.0% | 2 / 2 | 1 / 1 | 0M | 0M |
| Q4 2023 | 5 | 0M | 0.0% | 0 / 1 | 2 / 2 | 0M | 0M |
| Q3 2023 | 7 | 0M | 0.0% | 4 / 0 | 3 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1 funds held AHG in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of AHG | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 14,973 | 0.00% | $22.76K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Zhongliang Xie | Director | – | – | Apr 6, 2026 |
| Jianqiang Xu | Director | – | – | Mar 30, 2026 |
| Wenjuan Liu | Director | – | – | Mar 27, 2026 |
| Stephen P. Brown | Director | – | – | Mar 18, 2026 |
| Yilin Wang | Director | – | – | Mar 18, 2026 |
| Zhe Liu | Director | – | – | Mar 18, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Akso Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 9,131 shares on Oct 1, 2026 over the last 90 days.
See a number that looks wrong?